Loading insider details...
Beta
Latest Form 4 (Jun 2, 2026): Purchase of 150,000 CNTB shares, $371.6K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 2, 2026 | Connect Biopharma Holdings Ltd (CNTB) | Purchase | 150,000 | $371.6K |
| May 11, 2026 | Atara Biotherapeutics, Inc. (ATRA) | Sale | 313,446 | $3.17M |
| Apr 1, 2026 | Connect Biopharma Holdings Ltd (CNTB) | Purchase | 1,160,000 | $4.00M |
| Mar 19, 2026 | Atara Biotherapeutics, Inc. (ATRA) | Exercise/Conversion | 259,163 | $25.92 |
| Jan 15, 2026 | Atara Biotherapeutics, Inc. (ATRA) | Sale | 80,554 | $489.0K |
| Dec 1, 2025 | Atara Biotherapeutics, Inc. (ATRA) | Exercise/Conversion | 48,737 | $4.87 |
| Aug 20, 2025 | Atara Biotherapeutics, Inc. (ATRA) | Purchase | 55,000 | $670.4K |
| Jul 21, 2025 | Atara Biotherapeutics, Inc. (ATRA) | Purchase | 19,335 | $186.4K |
| Jun 8, 2023 | Alaunos Therapeutics, Inc. (TCRT) | Grant/Award | 100,000 | n/a |
| Feb 23, 2023 | WINDTREE THERAPEUTICS INC /DE/ (WINT) | In-the-Money Exercise | 1,112,308 | $156.9K |